This Safety Data Sheet contains information concerning the potential risks to those involved in handling, transporting and working with the material, as well as describing potential risks to the consumer and the environment. This information must be made available to those who may come into contact with the material or are responsible for the use of the material. This Safety Data Sheet is prepared in accordance with formatting described in the REACH Regulation (EC) No 1907/2006, and described in CLP Regulation (EC) No 1272/2008. SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier IKOpro PU Insulation Adhesive Relevant identified uses of the substance or mixture and uses advised against Adhesive Details of the supplier of the safety data sheet IKO PLC Appley Lane North Appley Bridge, Wigan Lancashire WN6 9AB Tel: 0844 412 7225 Fax: 0844 412 7205 Emergency telephone number Tel: 0844 412 7228 (available 08:30 to 17:00 weekdays)
SECTION 2: Hazards Identification 2.1 Classification of the substance or mixture Classification under CHIP:
Xn: R20; Xi: R36/37/38; Xn: R40; Sens.: R42/43; Xn: R48/20
Most important adverse effects:
Harmful by inhalation. Irritating to eyes, respiratory system and skin. Limited evidence of a carcinogenic effect. May cause sensitisation by inhalation and skin contact. Harmful: danger of serious damage to health by prolonged exposure through inhalation.
2.2 Label elements
Label elements under CHIP: Hazard symbols: Harmful. Risk phrases: R20: Harmful by inhalation.
R36/37/38: Irritating to eyes, respiratory system and skin.
Page 1 of 8
R40: Limited evidence of a carcinogenic effect. R42/43: May cause sensitisation by inhalation and skin contact. R48/20: Harmful: danger of serious damage to health by prolonged exposure through inhalation.
Safety phrases:
S36/37: Wear suitable protective clothing and gloves. S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). S63: In case of accident by inhalation, remove casualty to fresh air and keep at rest.
Precautionary phrases: Contains isocyanates. See information supplied by the manufacturer. Contains benzoyl chloride. May produce an allergic reaction. 2.3 Other hazards PBT: This product is not identified as a PBT substance.
SECTION 3: Composition / information on ingredients 3.2 Mixtures Hazardous ingredients: DIPHENYLMETHANE DIISOCYANATE (ISOMERS AND HOMOLOGUES) EINECS CHIP Classification CLP Classification
SE 3: H335; Skin Irrit. 2: H315; Resp. Sens. 1: H334; Skin Sens. 1: H317; STOT SE 2: H371; STOT RE 2: H373
SECTION 4: First Aid Measures 4.1. Description of first aid measures Skin contact: Remove all contaminated clothes and footwear immediately unless stuck to skin.
Remove from skin with paper or towel. Wash effected area thoroughly with soap and water. Seek medical advice if symptoms persist.
Eye contact:
Bathe the eye with running water for 15 minutes. Transfer to hospital for specialist examination. Ingestion:
Do not induce vomiting. If conscious, give half a litre of water to drink immediately. Transfer to hospital as soon as possible.
Inhalation:
Remove casualty from exposure ensuring one's own safety whilst doing so. Obtain medical help if there is difficulty breathing.
Page 2 of 8 I 4.2. Most important symptoms and effects, both acute and delayed Skin contact: There may be irritation and redness at the site of contact. Onset of symptoms may be Eye contact: There may be irritation and redness. Ingestion:
Nausea and stomach pain may occur. There may be vomiting.
Inhalation:
Exposure may cause coughing or wheezing. There may be congestion of the lungs causing severe shortness of breath. Onset of symptoms may be delayed.
Delayed / immediate effects: No data available. 4.3. Indication of any immediate medical attention and special treatment required Immediate / special treatment: Show this safety data sheet to the doctor in attendance. SECTION 5: Firefighting Measures 5.1 Extinguishing media: Extinguishing media: Carbon dioxide. Alcohol or polymer foam. Dry chemical powder. 5.2 Special hazards arising from the substance or mixture Exposure hazards: In combustion emits toxic fumes. 5.3 Advice for fire fighters Advice for fire-fighters: Wear self-contained breathing apparatus. Wear protective clothing to prevent contact with skin and eyes. SECTION 6: Accidental Release Measures 6.1 Personal precautions, protective equipment and emergency procedures Personal precautions: Mark out the contaminated area with signs and prevent access to unauthorised
personnel. Turn leaking containers leak-side up to prevent the escape of liquid. Refer to section 8 of SDS for personal protection details.
Environmental precautions Environmental precautions: Do not discharge into drains or rivers. Contain the spillage using bunding. 6.3 Methods and materials for containment and clearing up
Clean-up procedures: Absorb into dry earth or sand. Neutralise with dilute hydrochloric acid. Nuetralise with
water containing 1% wetting agent To avoid build up of pressure due to the evolution of carbon dioxide, do not seal containers until fully reacted.
References to other sections Refer to Section 8 of SDS. Refer to section 13 of SDS
Page 3 of 8
SECTION 7: Handling and Storage 7.1 Precautions for safe handling Handling requirements: Ensure there is sufficient ventilation of the area. Avoid direct contact with the substance. 7.2 Conditions for safe storage, including any incompatibilities Storage conditions: Store in cool, well ventilated area. Keep container tightly closed. Suitable packaging: Must only be kept in original packaging. 7.3 Specific end use(s): No special requirement
SECTION 8. Exposure Controls/Personal Protection 8.1 Control parameters Workplace exposure limits: Respirable dust 8 hour TWA 15min STEL 8 hour TWA 15min STEL Hazardous ingredients: DIPHENYLMETHANE DIISOCYANATE (ISOMERS AND HOMOLOGUES) Workplace exposure limits: Respirable dust 8 hour TWA 15min STEL 8 hour TWA 15min STEL DNEL/PNEC Values DNEL / PNEC: No data available. 8.2 Exposure controls Engineering measures:
Ensure there is exhaust ventilation of the area.
Respiratory protection:
In case of insufficient ventilation wear suitable respiratory equipment. If exposure levels are likely to be exceeded, use a full face mask fitted with an organic AXP3 filter for short term low level exposures. For long term or high level exposures, compressed airline breathing apparatus should be used.
Hand protection:
Avoid skin contact. For repeated exposure use Viton or 4H chemical gloves for low exposure use nitrile gloves. The user has a legal duty to carry out a COSHH risk assessment to determine the correct glove.
Eye protection: Skin protection:
Wear protective work clothing sufficient to avoid skin contact. Wash hands regularly, before breaks and at the end of the working day.
Environmental:
Page 4 of 8
SECTION 9: Physical and Chemical Properties 9.1 Information on basic physical and chemical properties Evaporation rate: Slow Oxidising: Solubility in water: Reacts with water. Viscosity: Flash point°C: >200 Autoflammability°C: >400 Vapour pressure: <0.00001hPa Relative density: 1.12 9.2 Other information No data available SECTION 10: Stability and Reactivity 10.1 Reactivity Stable under recommended transport or storage conditions. 10.2 Chemical stability Stable under normal conditions. 10.3 Possibility of hazardous reactions Hazardous reactions will not occur under normal transport or storage conditions. 10.4 Conditions to avoid Heat. Moist air. 10.5 Incompatible materials
Materials to avoid: Water. Strong acids. Strong bases. 10.6 Hazardous decomposition products
In combustion emits toxic fumes. SECTION 11: Toxicological Information The information below may not be consistent with the material classification in Section 2 if specific ingredient classifications are mandated by a competent authority. In addition, toxicological data on ingredients may not be reflected in the material classification and/or the signs and symptoms of exposure, because an ingredient may be present below the threshold for labelling, an ingredient may not be available for exposure, or the data may not be relevant to the material as a whole. 11.1 Information on toxicological effects
Toxicity values: Route Species Test
Page 5 of 8 Relevant effects for mixture: Effect 11.2 Symptoms/routes of exposure Skin contact: There may be irritation and redness at the site of contact. Onset of symptoms may be
Eye contact: There may be irritation and redness. Ingestion:
Nausea and stomach pain may occur. There may be vomiting.
Inhalation:
Exposure may cause coughing or wheezing. There may be congestion of the lungs causing severe shortness of breath. Onset of symptoms may be delayed.
Delayed / immediate effects: No data available. Other information: Not applicable. SECTION 12: Ecological Information 12.1 Toxicity Ecotoxicity values: Persistence and degradability
Biodegradable in part only. 12.3 Bioaccumulative potential
No data available. 12.4 Mobility in soil
Reacts with water to form an insoluble polyurea. Do not discharge in to natural waters without pre-treatment. 12.5 Results of PBT and vPvB assessment PBT identification: This product is not identified as a PBT substance. 12.6 Other adverse effects
No data available.
Disposal operations:
Wet waste: Arrange for disposal by a licenced waste disposal company
Disposal of packaging:
Arrange for disposal by a licenced waste disposal company
The user's attention is drawn to the possible existence of regional or national regulations regarding disposal.
SECTION 14: Transport Information Transport class:
This product does not require a classification for transport.
SECTION 15: Regulatory Information 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture Specific regulations: This product is classifed as a mixture. CLP classification for information only. Persons
already sensitised to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas filter (i.e. type A1 according to standard EN 14387) is used.
Chemical Safety Assessment Chemical safety assessment: A chemical safety assessment has not been carried out for the substance or the mixture by the supplier. SECTION 16: Other Information This safety data sheet is prepared in accordance with Commission Regulation (EU) No 453/2010. * indicates text in the SDS which has changed since the last revision. Phrases used in s.2 and 3: H315
May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Suspected of causing cancer <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
May cause damage to organs <or state all organs affected, if known> through prolonged or repeated exposure <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
Limited evidence of a carcinogenic effect.
May cause sensitisation by skin contact.
Harmful: danger of serious damage to health by prolonged exposure through inhalation.
Legal disclaimer: The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. This company shall not be held liable for any damage resulting from handling or from contact with the above product.
Page 7 of 8
IKO PLC Literature Enquiries Tel: 0844 412 8554
Sales Support Appley Lane North, Appley Bridge, Wigan, Lancashire WN6 9AB
Tel: 0844 873 1062 Fax: 0844 873 1067 E-Mail:
Technical & Design Services
Appley Lane North, Appley Bridge, Wigan, Lancashire WN6 9AB
Tel: 0844 412 7228 Fax: 0844 412 7229 E-Mail: [email protected]
Whilst every care is taken to see that the information given in this literature is correct and up to date it is not intended to form part of any contract or give rise to any collateral liability, which is hereby specifically excluded. Intending purchasers of our materials should therefore verify with the company whether any changes in our specification or application details or otherwise have taken place since this literature was issued. Company Registered in England No. 2678296 – Registered Office: Appley Lane North, Appley Bridge, Wigan, Lancashire, WN6 9AB
Page 8 of 8
(current stock is imported from USA - Australian Made available soon ) A little while ago, the Dr Oz TV Show exposed the weight loss benefits of Green Coffee Bean Extract that had 45% chlorogenic acids which is the active ingredient for weight loss. In a nutshell . What makes Green Coffee Bean Extract effective? The active ingredient within the green coffee bean extract that produc
ARTEMISININ-COMPOUNDS LITERATURE LIST (2/05) (cancer-related papers are marked with an asterisk *) Abdin MZ, Israr M, Rehman RU, Jain SK. Artemisinin, a novel antimalarial drug: biochemical and molecular approaches for enhanced production. Planta Med 69(4):289- 299, 2003. Ai J, Gao HH, He SZ, Wang L, Luo DL, Yang BF. Effects of matrine, artemisinin, and tetrandrine on cytosolic [Ca2+]I in